FAQ/Help |
Calendar |
Search |
Today's Posts |
07-23-2016, 01:04 PM | #1 | |||
|
||||
Senior Member
|
COMMENT
These findings put to rest the notion that rasagiline, and likely other MAO-B inhibitors, will play a meaningful role in the treatment of cognitive dysfunction in PD. Although a previous study (Mov Disord 2011; 26:1851) suggested attention and executive dysfunction may be improved by rasagiline, based on the current results I would not recommend use of a MAO-B for the cognitive-dysfunction feature of PD. Can Rasagiline Enhance Cognition in Parkinson Disease? - NEJM Journal Watch
__________________
In the last analysis, we see only what we are ready to see, what we have been taught to see. We eliminate and ignore everything that is not a part of our prejudices. ~ Jean-Martin Charcot The future is already here — it's just not very evenly distributed. William Gibson |
|||
Reply With Quote |
"Thanks for this!" says: |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
Anyone seen this? ECGC plus Rasagaline | Parkinson's Disease |